Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 B-type natriuretic peptide measurement in heart failure.

Literature DB >> 15471158

B-type natriuretic peptide measurement in heart failure.

Abstract

Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2004 PMID： 15471158 PMCID： PMC6654669 DOI： 10.1002/clc.4960270903

Source DB: PubMed Journal: Clin Cardiol ISSN： 0160-9289 Impact factor: 2.882

69 in total

1. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

Authors: R W Troughton; C M Frampton; T G Yandle; E A Espiner; M G Nicholls; A M Richards
Journal: Lancet Date: 2000-04-01 Impact factor: 79.321

Review 2. Aldosterone and renin measurements.

Authors: S Cartledge; N Lawson
Journal: Ann Clin Biochem Date: 2000-05 Impact factor: 2.057

3. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.

Authors: P L Selvais; A Robert; S Ahn; F van Linden; J M Ketelslegers; H Pouleur; M F Rousseau
Journal: J Card Fail Date: 2000-09 Impact factor: 5.712

4. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.

Authors: M W Smith; E A Espiner; T G Yandle; C J Charles; A M Richards
Journal: J Endocrinol Date: 2000-11 Impact factor: 4.286

5. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.

Authors: N Nagaya; T Nishikimi; M Uematsu; T Satoh; S Kyotani; F Sakamaki; M Kakishita; K Fukushima; Y Okano; N Nakanishi; K Miyatake; K Kangawa
Journal: Circulation Date: 2000-08-22 Impact factor: 29.690

6. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

Authors: R M Mills; T H LeJemtel; D P Horton; C Liang; R Lang; M A Silver; C Lui; K Chatterjee
Journal: J Am Coll Cardiol Date: 1999-07 Impact factor: 24.094

7. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

Authors: V Cheng; R Kazanagra; A Garcia; L Lenert; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal: J Am Coll Cardiol Date: 2001-02 Impact factor: 24.094

8. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.

Authors: Q Dao; P Krishnaswamy; R Kazanegra; A Harrison; R Amirnovin; L Lenert; P Clopton; J Alberto; P Hlavin; A S Maisel
Journal: J Am Coll Cardiol Date: 2001-02 Impact factor: 24.094

9. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors: W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

10. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale.

Authors: M Bando; Y Ishii; Y Sugiyama; S Kitamura
Journal: Respir Med Date: 1999-07 Impact factor: 3.415

1 in total

Review 1. The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors: Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal: Biomed Pharmacother Date: 2017-06-07 Impact factor: 6.529

1 in total